Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia

BMC Women's Health

Volumn 11, Issue , 2011, Pages

  Kivistik, Alice ^a   Lang, Katrin ^b   Baili, Paolo ^c   Anttila, Ahti ^d   Veerus, Piret ^a  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cervical cancer screening; Estonia; Reasons for non participation

Indexed keywords

ADULT; ARTICLE; AWARENESS; CANCER RISK; CANCER SCREENING; CROSS-SECTIONAL STUDY; ESTONIA; FEMALE; HEALTH PROGRAM; HUMAN; PAPANICOLAOU TEST; QUESTIONNAIRE; SOCIAL PARTICIPATION; UTERINE CERVIX CANCER; ATTITUDE TO HEALTH; FEAR; MASS SCREENING; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; STATISTICS; UTERINE CERVIX TUMOR; VAGINA SMEAR; WOMEN'S HEALTH;

ADULT; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; ESTONIA; FEAR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 80053375611     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-11-43     Document Type: Article

References (19)

1. The GLOBOCAN 2008 database. Cancer incidence, mortality and prevalence worldwide. International Agency for Reasearch on Cancer. , http://globocan.iarc.fr
2. Arbyn M, Castellsaguè, Sanjosè de S, Bruni L, Saraiya M, Bray F. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011,
3. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hédelin G, Matsuda T, Møller H, Möller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaqualani M, Roazzi P, Lisi D, . EUROCARE Working Group EUROCARE-3:survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 2003, 14:61-118. EUROCARE Working Group.
4. Arbyn M, Antoine J, Valerianova Z, Mägi M, Stengrevics A, Smailyte G, Suteu O, Micheli A. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania. Tumori 2010, 96:517-523.
5. Arbyn M, Rebolj M, De Kok IM, Fender M, Becker N, O'Reilly M, Andrea B. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009, 45:2671-2678. 10.1016/j.ejca.2009.07.016, 19695867.
6. Anttila A, Arbyn M, Veerus P. Barriers in cervical cancer screening programs in new European Union member states. Tumori 2010, 96:515-516.
7. Bos AB, Rebolj M, Habbema JD, van Balleqooijen M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006, 119:2372-2375. 10.1002/ijc.22114, 16858676.
8. Raud T, Klaar U. Pilot project of cervical cancer in Estonia (article in Estonian). Eesti Arst 2006, 85:834-8.
9. Veerus P, Arbyn M, Amati C, Paolo B, . EUROCHIP Working Group Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-test in Estonia. Tumori 2010, 96:524-528. EUROCHIP Working Group.
10. Anttila A, Pukkala E, Söderman B. Effect of organised screening on cervical cancer incidence and mortality in Finland 1963-1995, recent increase in cervical cancer incidence. Int J Cancer 1999, 83:59-65. 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N, 10449609.
11. Veerus P. WP-4 Cervical screening study protocol for Estonia. EUROCHIP 3 Interm Report 2010, Micheli A.
12. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic review. Prev Med 2008, 46:87-98. 10.1016/j.ypmed.2007.09.003, 17942147.
13. Segnan N, Senore C, Giordano L, Ponti A, Ronco G. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998, 84:348-353.
14. Baron R, Melillo S, Rimer B. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers: a systematic review of provider reminders. Am J Prev Med 2010, 38:110-17. 10.1016/j.amepre.2009.09.031, 20117566.
15. Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2010, 128:2681-2587.
16. Anttila A, Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. European Journal of Cancer 2009, 45:2685-2708. 10.1016/j.ejca.2009.07.017, 19744852.
17. Orbell S, Cromble I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage?. J R Soc Med 1995, 88:389-394. 1295268, 7562807.
18. Agurto I, Bishop A, Sanchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med 2004, 39:91-98. 10.1016/j.ypmed.2004.03.040, 15207990.
19. Corral F, Cueva P, Yepez J. Limited education as a risk factor in cervical cancer. Bull Pan Am Health Organ (PAHO) 1996, 30:322-329.